Eight-Week Creatine-Glucose Supplementation Alleviates Clinical Features of Long COVID
Slankamenac J, Ranisavljev M, Todorovic N, Ostojic J, Stajer V, Candow DG, Ratgeber L, Betlehem J, Acs P, Ostojic SM
Journal of nutritional science and vitaminology · 7 citations
Review labels
Neutral facts our review recorded about how this study was done. They describe method, never whether we like the result.
How it was studied
- Design
- Randomized controlled trial (indexed by PubMed)
- Studied in
- People
- Main outcome
- Health markers and function
Who paid for it
- Funding
- Funding not disclosed
Publication
- Published
- 2024-04-29 · J Nutr Sci Vitaminol (Tokyo) · vol. 70 · issue 2 · pp. 174–178
- Publisher
- Center for Academic Publications Japan
- Cited
- 16 citations · more than 95% of similar papers · 4.2× the field average
- Impact
- Top 10% most cited in its field
- References
- 8 works
- Access
- Open access (free to publish)
- Research areas
- Long-Term Effects of COVID-19 · Fibromyalgia and Chronic Fatigue Syndrome Research · Exercise and Physiological Responses
- Keywords
- Creatine, Medicine, Placebo, Internal medicine, Analysis of variance, Randomized controlled trial, Creatine Monohydrate, Endocrinology
- MeSH
- brain, humans, fatigue, creatine, glucose, treatment outcome, double-blind method, dietary supplements, adult, middle aged, female, male, covid-19, sars-cov-2, post-acute covid-19 syndrome
10 authors
From RS, CA, HU, NO
- Jelena SlankamenacUniversity of Novi Sad
- Marijana RanisavljevUniversity of Novi Sad
- Nikola TodorovićUniversity of Novi Sad
- Jelena Nesovic OstojicUniversity of Novi Sad
- Valdemar ŠtajerUniversity of Novi Sad
- Darren Glenn CandowUniversity of Regina
Abstract
Preliminary studies demonstrated beneficial effects of dietary creatine across different post-viral fatigue syndromes. Creatine is often co-administered with glucose to improve its potency yet whether glucose boost the efficacy of creatine in long COVID remains currently unknown. In this report, we investigate the effects of 8-wk creatine intake with and without glucose on patient-reported outcomes, exercise tolerance, and tissue creatine levels in patients with long COVID. Fifteen male and female long COVID adult patients (age 39.7±16.0 y; 9 women) with moderate fatigue and at least one of additional long COVID-related symptoms volunteered to participate in this randomized controlled parallel-group interventional trial. All patients were allocated in a double-blind parallel-group design (1 : 1 : 1) to receive creatine (8 g of creatine monohydrate per day), a mixture of creatine and glucose (8 g of creatine monohydrate and 3 g of glucose per day), or placebo (3 g of glucose per day) t.i.d. during an 8-wk intervention interval. Two-way ANOVA with repeated measures (treatment vs. time interaction) revealed significant differences in changes in total creatine levels between the groups, showing an interaction effect at two brain locations (right precentral white matter F=34.740, p=0.008; partial η2=0.72; left paracentral grey matter F=19.243, p=0.019; partial η2=0.88), with creatine and creatine-glucose outcompeted placebo to elevate creatine levels at these two locations. Several long COVID symptoms (including body aches, breathing problems, difficulties concentrating, headache, and general malaise) were significantly reduced in creatine-glucose group at 8-wk follow-up (p≤0.05); the effect sizes for reducing body aches, difficulties concentrating, and headache were 1.33, 0.80, and 1.12, respectively, suggesting a large effect of creatine-glucose mixture for these outcomes. Our preliminary findings suggest that supplying exogenous creatine with glucose could be recommended as an effective procedure in replenishing brain creatine pool and alleviating long COVID features in this prevalent condition.
Abstract via Europe PMC. Copyright remains with the authors or publisher.
Community trust
Loading…
How much do you trust this study's findings?
Comments
Sign in to rate, comment on or flag this study.Sign inSomething wrong here?
Flag this study if its information, labels or funding look wrong. An editor reviews every flag.
Sign in to rate, comment on or flag this study.Sign inEducational information about published research. Not medical advice, and not a recommendation to start or stop anything.